Viridos Stock

viridos.comEnergy / Clean EnergyFounded: 2005Funding to Date: $35.4MM

Viridos a biotechnology company harnessing the power of algae to make renewable, low carbon and energy dense liquid fuels for heavy duty transportation applications.

Register To Buy and Sell Shares

For more details on financing and valuation for Viridos, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Viridos’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Viridos.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Hamilton Smith Ph.D
Co-Founder, Board Member & Chief Scientific Officer
David Kiernan MD
Co-Founder & Board Member
Oliver Fetzer Ph.D
Board Member & Chief Executive Officer
Craig Venter Ph.D
Co-Founder & Scientific Advisor

Board Members

Alfonso Romo
Plenus
Edgardo Cantu
Kok-Thay Lim
Martine Rothblatt Ph.D
United Therapeutics
Tina Nova Ph.D
Barry Schuler
Draper Fisher Jurvetson Management
Derrik Huat
Gregory Lucier
Invitrogen
Oliver Fetzer Ph.D
Reinhard Ambros Ph.D
William McKee
Clyde Hutchison Ph.D
David Kiernan MD
Juan Enriquez
Excel Venture Management
Justin Adams
Shaun Healey
BP Ventures
Tan Thay
Genting Genomics

Frequently Asked Questions About Viridos’ Stock

plusminus
Can you buy Viridos’ stock?
Viridos is not publicly traded on NYSE or NASDAQ in the U.S. To buy Viridos’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Viridos’ stock?
Yes, you can sell stock of a private company like Viridos. Forge can help you sell your Viridos stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Viridos’ stock price?
Viridos is a privately held company and therefore does not have a public stock price. However, you may access Viridos’ private market stock price with Forge Data.
plusminus
What is Viridos’ stock ticker symbol?
Viridos does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Synthetic Genomics and ExxonMobil Renew Algae Biofuels Research Agreement
Synthetic Genomics, Inc. and ExxonMobil announced today that they have extended their agreement to conduct joint research into advanced algae biofuels after making significant progress in understanding algae genetics, growth characteristics and increasing oil production.
Synthetic Genomics Launches Vmax™ Express, a Next-Generation Protein Expression Platform for the Biotech Industry
SAN DIEGO, Jan. 9, 2017 /PRNewswire/ -- Synthetic Genomics Inc. announced today that its subsidiary, SGI-DNA, has...
Synthetic Genomics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Therapeutics Using Synthetic Genomics' Replicon RNA Technology
SAN DIEGO, Jan. 5, 2017 /PRNewswire/ -- Synthetic Genomics, Inc., announced today that it has entered a research and...
Updated on: May 21, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.